Maat Pharma SA (MAAT) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.853x

Based on the latest financial reports, Maat Pharma SA (MAAT) has a cash flow conversion efficiency ratio of -1.853x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-15.37 Million ≈ $-17.97 Million USD) by net assets (€8.29 Million ≈ $9.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Maat Pharma SA market capitalisation for the company's overall valuation and market capitalisation.

Maat Pharma SA - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Maat Pharma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Maat Pharma SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maat Pharma SA ranked by their cash flow conversion efficiency. See Maat Pharma SA (MAAT) debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Home Capital Rentals SOCIMI S.A. MC:YHCR	0.021x
Digitalx Ltd AU:DCC	-0.023x
Sound Group Inc. NASDAQ:SOGP	N/A
KAISA GROUP HLDGS F:KG5	N/A
NUREXONE BIOLOGIC INC. F:J90	-0.426x
Creative Realities Inc NASDAQ:CREX	0.057x
Nureca Limited NSE:NURECA	0.022x
TPC Consolidated Ltd AU:TPC	-0.057x

Annual Cash Flow Conversion Efficiency for Maat Pharma SA (2017–2024)

The table below shows the annual cash flow conversion efficiency of Maat Pharma SA from 2017 to 2024. View MAAT share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.34 Million ≈ $12.08 Million	€-22.04 Million ≈ $-25.77 Million	-2.132x	-133.76%
2023-12-31	€20.47 Million ≈ $23.93 Million	€-18.67 Million ≈ $-21.83 Million	-0.912x	-94.04%
2022-12-31	€26.81 Million ≈ $31.34 Million	€-12.61 Million ≈ $-14.74 Million	-0.470x	-136.32%
2021-12-31	€39.86 Million ≈ $46.60 Million	€-7.93 Million ≈ $-9.27 Million	-0.199x	+45.47%
2020-12-31	€15.94 Million ≈ $18.63 Million	€-5.81 Million ≈ $-6.80 Million	-0.365x	-133.18%
2019-12-31	€-4.57 Million ≈ $-5.34 Million	€-5.02 Million ≈ $-5.87 Million	1.099x	+136.04%
2018-12-31	€1.27 Million ≈ $1.48 Million	€-3.87 Million ≈ $-4.53 Million	-3.050x	-315.12%
2017-12-31	€5.27 Million ≈ $6.16 Million	€-3.87 Million ≈ $-4.53 Million	-0.735x	--

About Maat Pharma SA

PA:MAAT France Biotechnology

Market Cap

$35.73 Million

€30.56 Million EUR

Market Cap Rank

#23277 Global

#363 in France

Share Price

€1.63

Change (1 day)

-18.50%

52-Week Range

€1.08 - €7.78

All Time High

€13.95